Acute anaphylactic reaction to expired chlorpheniramine injection
نویسندگان
چکیده
منابع مشابه
Anaphylactic reaction to chymopapain injection: A review and anesthesia considerations
The Food and Drug Administration (FDA) recently has re-released chymopapain, an injectable proteolytic enzyme used as an alternative to lumbar laminectomy in selected patients. The reported success rate, over 800%, has inspired an increasing usage of chymopapain. However, there is a reported 1 % incidence of anaphylaxis upon injection of this drug. The authors describe the means of early recogn...
متن کاملAnaphylactic reaction to camomile tea.
BACKGROUND A type-IV-allergic reaction to German camomile (Matricaria chamomilla) in a form of allergic contact dermatitis is not unusual. However, only a few cases of anaphylactic reaction to camomile have been described in the literature. CASE SUMMARY We present the case of a 38-year-old Caucasian man who developed an episode of severe anaphylaxis with generalized urticaria, angioedema and ...
متن کاملDangerous anaphylactic reaction to mustard
Corresponding author: Krzysztof Pałgan MD Department of Allergology, Clinical Immunology and Internal Diseases Nicolaus Copernicus University Collegium Medicum 75 Ujejskiego St 85-168 Bydgoszcz, Poland Phone: +48 52 365 54 16 Fax: +48 52 348 40 76 E-mail: [email protected] Department of Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum of L. Rydygier in Bydgoszcz, Nicolaus C...
متن کاملParallel infusion of hydrocortisone +/- chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites.
OBJECTIVE To investigate the efficacy of continuous infusion of hydrocortisone with or without chlorpheniramine bolus against early adverse reactions to polyspecific antivenom. DESIGN AND SETTING Prospective, double-blind, randomised, placebo-controlled trial at General Hospital, Anuradhapura, Sri Lanka. SUBJECTS 52 patients with snake envenoming were randomised to receive infusion of hydro...
متن کاملAnaphylactic reaction to pemetrexed: a case report.
Pemetrexed is approved to treat non-small cell lung cancer and has an overall favorable toxicity profile. We describe a 58-year-old man who developped an anaphylactic shock within few minutes from the beginning of pemetrexed perfusion. Pemetrexed was discontinued and the patient's symptoms gradually resolved with administration of symptomatic treatment. Serum tryptase level remained normal and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Acute Disease
سال: 2014
ISSN: 2221-6189
DOI: 10.1016/s2221-6189(14)60035-4